NZ630831A - Compositions and methods for administration of vaccines against dengue virus - Google Patents
Compositions and methods for administration of vaccines against dengue virusInfo
- Publication number
- NZ630831A NZ630831A NZ630831A NZ63083113A NZ630831A NZ 630831 A NZ630831 A NZ 630831A NZ 630831 A NZ630831 A NZ 630831A NZ 63083113 A NZ63083113 A NZ 63083113A NZ 630831 A NZ630831 A NZ 630831A
- Authority
- NZ
- New Zealand
- Prior art keywords
- dengue virus
- administration
- compositions
- methods
- vaccines against
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24141—Use of virus, viral particle or viral elements as a vector
- C12N2770/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
Disclosed is a method for rapid induction of neutralizing antibodies in a subject against three or more dengue virus serotypes, comprising, subcutaneous administration of two or more doses of a single formulation of a live, attenuated dengue virus vaccine to a subject at two or more anatomical locations on the same day.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/492,884 US8968996B2 (en) | 2009-06-01 | 2012-06-10 | Compositions and methods for rapid immunization against dengue virus |
PCT/US2013/045041 WO2013188315A1 (en) | 2012-06-10 | 2013-06-10 | Compositions and methods for administration of vaccines against dengue virus |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ630831A true NZ630831A (en) | 2019-02-22 |
Family
ID=48652375
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ630831A NZ630831A (en) | 2012-06-10 | 2013-06-10 | Compositions and methods for administration of vaccines against dengue virus |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP2858668A1 (en) |
JP (2) | JP2015520196A (en) |
CA (1) | CA2915027A1 (en) |
NZ (1) | NZ630831A (en) |
TW (1) | TW201402143A (en) |
WO (1) | WO2013188315A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2016504315A (en) * | 2012-12-14 | 2016-02-12 | タケダ ワクチン, インコーポレイテッドTakeda Vaccines, Inc. | Compositions, methods of administration and uses for trivalent dengue virus formulations |
CN113637693A (en) | 2013-03-15 | 2021-11-12 | 武田疫苗股份有限公司 | Compositions and methods for dengue virus chimeric constructs in vaccines |
MX2018000052A (en) | 2015-07-02 | 2018-05-11 | Primevax Immuno Oncology Inc | Compositions and methods for combination therapy with dengue virus and dendritic cells. |
WO2017053873A1 (en) | 2015-09-26 | 2017-03-30 | PrimeVax Immuno-Oncology, Inc. | Compositions and methods for producing dendritic cells |
MY192806A (en) * | 2016-04-13 | 2022-09-09 | Takeda Vaccines Inc | Compositions and methods of vaccination against dengue virus in children and young adults |
TWI625393B (en) * | 2016-11-15 | 2018-06-01 | 國立清華大學 | A vaccine kit against multiple dengue virus serotypes and preparation and application thereof |
JP2020500847A (en) | 2016-11-16 | 2020-01-16 | プライムヴァックス イミュノ−オンコロジー,インク. | Combination immunotherapy for the treatment of cancer |
US11464815B2 (en) | 2018-09-05 | 2022-10-11 | Takeda Vaccines, Inc. | Dengue vaccine unit dose and administration thereof |
US11426461B2 (en) | 2018-09-05 | 2022-08-30 | Takeda Vaccines, Inc. | Methods for preventing dengue and hepatitis A |
US20220226401A1 (en) | 2018-09-05 | 2022-07-21 | Takeda Vaccines, Inc. | Dengue vaccine unit dose and administration thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8110196B2 (en) * | 2005-04-29 | 2012-02-07 | Polytopas LLC | Methods and compositions for polytopic vaccination |
FR2906724B1 (en) * | 2006-10-04 | 2009-03-20 | Sanofi Pasteur Sa | METHOD OF IMMUNIZATION AGAINST THE 4 SEROTYPES OF DENGUE. |
US8968996B2 (en) * | 2009-06-01 | 2015-03-03 | Takeda Vaccines, Inc. | Compositions and methods for rapid immunization against dengue virus |
US9211323B2 (en) * | 2009-06-01 | 2015-12-15 | Takeda Vaccines, Inc. | Compositions and methods for administration of vaccines against dengue virus |
-
2013
- 2013-06-10 TW TW102120553A patent/TW201402143A/en unknown
- 2013-06-10 JP JP2015516276A patent/JP2015520196A/en active Pending
- 2013-06-10 WO PCT/US2013/045041 patent/WO2013188315A1/en active Application Filing
- 2013-06-10 EP EP13729909.5A patent/EP2858668A1/en not_active Withdrawn
- 2013-06-10 NZ NZ630831A patent/NZ630831A/en not_active IP Right Cessation
- 2013-06-10 CA CA2915027A patent/CA2915027A1/en not_active Abandoned
-
2018
- 2018-02-23 JP JP2018030539A patent/JP2018090618A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
TW201402143A (en) | 2014-01-16 |
EP2858668A1 (en) | 2015-04-15 |
JP2018090618A (en) | 2018-06-14 |
CA2915027A1 (en) | 2013-12-19 |
WO2013188315A1 (en) | 2013-12-19 |
JP2015520196A (en) | 2015-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ630831A (en) | Compositions and methods for administration of vaccines against dengue virus | |
MX2018007627A (en) | Zika virus vaccine. | |
PH12019500289A1 (en) | Vaccines directed against a human enteroviruses | |
MX2012009581A (en) | Vaccines for use in the prophylaxis and treatment of influenza virus disease. | |
MX2015010305A (en) | Combination vaccine for respiratory syncytial virus and influenza. | |
PH12017501370A1 (en) | Bivalent swine influenza virus vaccine | |
NZ715459A (en) | A hyperbarically-inactivated microorganism, immunogenic compositions comprising same and methods for producing same | |
EA202090699A2 (en) | COMPOSITIONS CONTAINING A BUFFER, VACCINES THAT CONTAIN COMPOSITIONS CONTAINING A BUFFER, AND THEIR APPLICATION | |
MX346596B (en) | Immunostimulatory oligodeoxynucleotides. | |
PH12015501716B1 (en) | Anti-mycoplasma spp. subunit vaccine | |
MX2021013109A (en) | Process for preparing an attenuated tetravalent dengue vaccine. | |
PH12015501333A1 (en) | Method of making a mycoplasma vaccine | |
NZ731659A (en) | Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus | |
MX2022013912A (en) | Novel methods for inducing an immune response. | |
MX2016012052A (en) | Dimethyl fumarate and vaccination regimens. | |
MX2015017257A (en) | Compositions and methods of immunizing against c. difficile. | |
MX2016002823A (en) | Methods and compositions for viral vectored vaccines. | |
GB2515222A (en) | Use of flagellin as a vaccine | |
MX369039B (en) | Vaccine against porcine circo virus type 2. | |
WO2013173256A3 (en) | New and improved influenza vaccines | |
ES2503516R1 (en) | IMMUNOGENIC COMPLEX FOR VACCINATION AND METHOD OF OBTAINING | |
MX350718B (en) | Equine rhinitis vaccine. | |
MX2015007195A (en) | Preparation of live vaccines. | |
IN2013DE02372A (en) | ||
UA69683U (en) | Method for treatment of patients with steatohepatitis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PSEA | Patent sealed | ||
LAPS | Patent lapsed |